AndroGel Cost in Virginia 2026: Cash Price, Insurance, Medicaid, and Compounded Alternatives

What Is the Cash Price of AndroGel in Virginia in 2026?

The cash price for a 30-day supply of AndroGel 1.62% at Virginia retail pharmacies sits at approximately $510 in 2026, matching AbbVie's published list price. That figure applies to patients paying without insurance or a discount program. GoodRx coupons bring the cost down to roughly $400, $450 at select chains, though savings vary by zip code and pharmacy contract.

AndroGel comes in two concentrations: the original 1% gel in unit-dose packets and the 1.62% gel delivered via a metered-dose pump. The 1.62% formulation now dominates prescribing in Virginia because the lower volume of gel applied (each actuation delivers 20.25 mg testosterone) reduces accidental transfer risk to partners and children, a concern the FDA flagged in its 2009 black-box warning update [1].

The T-Trials, a coordinated set of seven placebo-controlled trials enrolling 788 men aged 65 and older with low testosterone (below 275 ng/dL), showed that transdermal testosterone produced meaningful improvements in sexual function and bone mineral density over 12 months [2]. Those findings underpin why clinicians continue prescribing testosterone gel even as cost pressures mount. A patient paying $510 cash for 12 months spends $6,120 annually before any savings program.

Generic testosterone gel (1%) entered the U.S. Market after patent expiration and is available at some Virginia pharmacies for $180, $260 per month cash, depending on the pharmacy. Patients who tolerate the higher application volume of the 1% formulation may find generic gel a practical cost-reduction step before moving to compounded options [3].

Does Virginia Medicaid Cover AndroGel?

Virginia Medicaid covers AndroGel and generic testosterone gel for male hypogonadism, but prior authorization (PA) is required. The PA criteria generally require a clinical diagnosis of hypogonadism (ICD-10 E29.1), two fasting morning serum testosterone values below 300 ng/dL drawn at least one week apart, and documentation that symptoms such as fatigue, decreased libido, or loss of muscle mass are present [4].

Virginia's Medicaid program is administered through managed care organizations (MCOs) including Anthem HealthKeepers Plus, Molina Healthcare, Optima Family Care, and Virginia Premier. Each MCO maintains its own preferred drug list (PDL), and generic testosterone gel 1% is typically the preferred agent. Brand AndroGel 1.62% may require a step-therapy failure with generic gel before the MCO approves it [5].

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy states: "We recommend testosterone therapy for men with classic androgen deficiency syndromes who have unequivocally low morning testosterone concentrations, with the goal of inducing and maintaining secondary sex characteristics and correcting symptoms" [6]. Virginia Medicaid PA forms explicitly reference this threshold, making the guideline language operationally relevant to approval decisions in the state.

Patients denied on the first PA submission should request a peer-to-peer review and submit laboratory printouts showing the time of draw. A 10 a.m. Or later draw will read lower than an 8, 9 a.m. Draw and may trigger an incorrect denial if a reviewer flags the timing as non-standard [7].

Is Compounded Testosterone Gel Legal in Virginia?

Compounded testosterone gel is legal in Virginia when prepared by a pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act and licensed by the Virginia Board of Pharmacy. A 503A pharmacy may compound testosterone gel for an individual patient based on a valid prescription from a licensed prescriber [8].

Virginia also accepts supply from 503B outsourcing facilities registered with the FDA, which compound in larger batches without patient-specific prescriptions and ship to licensed prescribers or clinics rather than directly to patients [9]. The practical cost difference is significant: a 503A compounded testosterone gel (typically testosterone cypionate in a transdermal base or micronized testosterone in a lipoderm base) runs approximately $120 per month, versus $510 for brand AndroGel. That is a $4,680 annual saving for a cash-pay patient.

Compounded testosterone is not FDA-approved as a finished drug product, meaning no phase III efficacy or bioequivalence data exist for any specific compounded formulation. The FDA has stated that compounded drugs are not approved and lack the same assurance of safety, effectiveness, and quality as approved products [10]. Absorption rates for compounded gels can vary by base formulation; a patient switching from AndroGel 1.62% to a compounded alternative should have serum testosterone retested at 4 weeks to confirm therapeutic levels [11].

Virginia law prohibits compounding of commercially available drug products unless the patient has a documented allergy, intolerance, or specific clinical need that the commercial product cannot meet. Because AndroGel is commercially available, a prescriber ordering compounded testosterone gel should document the clinical rationale, such as alcohol sensitivity to the commercial gel's ethanol base or a need for a custom dose not available commercially [12].

Which Insurance Plans Cover AndroGel in Virginia?

Most Virginia commercial insurance plans cover testosterone gel at tier 2 or tier 3 on the formulary, with generic gel at tier 2 and brand AndroGel at tier 3. Tier 3 copays in Virginia typically range from $50 to $90 per 30-day supply after deductible, though high-deductible health plan (HDHP) members may pay the full negotiated price until their deductible is met [13].

Major Virginia insurers with documented testosterone gel coverage include Anthem Blue Cross Blue Shield of Virginia, Cigna, Aetna, UnitedHealthcare, and Kaiser Permanente Mid-Atlantic. Humana Medicare Advantage plans in Virginia cover testosterone gel under Part D, but Medicare Part D plans are prohibited by law from covering drugs prescribed solely for the treatment of sexual dysfunction, so the diagnosis on the prescription must reflect hypogonadism, not erectile dysfunction [14].

Prior authorization triggers vary by plan. Anthem Blue Cross Blue Shield of Virginia's 2025 clinical criteria require serum testosterone below 300 ng/dL on two morning samples, symptom documentation, and a 90-day trial of generic testosterone gel 1% before approving brand AndroGel 1.62%. Cigna's criteria are similar but allow a physician attestation of intolerance to the 1% formulation to bypass the step-edit [15].

TRICARE beneficiaries at Virginia military installations, including Fort Gregg-Adams, Langley Air Force Base, and Naval Station Norfolk, access testosterone gel through TRICARE pharmacy benefits. The TRICARE formulary lists generic testosterone gel 1% as a preferred generic at $0 copay at military treatment facility pharmacies and $11 per 90-day supply at TRICARE mail order [16].

How Does the AbbVie Savings Card Work in Virginia?

The AbbVie myAbbVie Assist copay savings card reduces the monthly out-of-pocket cost for commercially insured Virginia patients to as low as $0 per 30-day AndroGel prescription, subject to a maximum annual benefit of $3,000 per calendar year. The card is not valid for patients enrolled in Medicare, Medicaid, or any other federal or state government health program [17].

Enrollment requires completing an online form at AbbVie's patient assistance site. The card is activated immediately and can be presented at any participating Virginia retail pharmacy. AbbVie processes the secondary payment electronically; the patient pays only the residual copay, which is $0 for most commercially insured plans [18].

The myAbbVie Assist program also includes a separate patient assistance program (PAP) for uninsured or underinsured Virginia patients who meet income eligibility criteria, generally household income at or below 400% of the federal poverty level. Under the PAP, qualifying patients may receive AndroGel at no cost through a 90-day supply shipped directly to their prescribing physician's office [19].

Patients who lose commercial insurance coverage mid-year lose eligibility for the copay card immediately. A Virginia patient who transitions to Medicaid, for example, must discontinue the card and work through Medicaid PA channels instead [20].

Can I Get AndroGel via Telehealth in Virginia?

Telehealth prescribing of AndroGel is permitted in Virginia. Testosterone is a Schedule III controlled substance under the Controlled Substances Act, which means prescribers must comply with DEA telemedicine rules. Under the DEA's special telemedicine registration rule finalized in 2023 and still operative in 2026, a prescriber may prescribe Schedule III substances via telemedicine after conducting a medical evaluation using real-time, two-way audio-visual technology [21].

Virginia law aligns with this federal framework. The Virginia Board of Medicine permits prescribing via telemedicine when the prescriber establishes a valid patient-physician relationship, which for controlled substances requires a live audio-visual visit, not asynchronous messaging alone [22]. A prescription generated from an audio-only call does not meet the standard for Schedule III substances.

Telehealth platforms serving Virginia residents, including HealthRX, typically require patients to complete a medical intake form, upload recent laboratory results (testosterone panel, complete blood count, and prostate-specific antigen), and then conduct a synchronous video visit with a licensed Virginia provider. If prior labs are not available, the platform orders them through a partnered diagnostic network before the prescribing visit [23].

The HealthRX Virginia Testosterone Prescribing Pathway uses a four-step qualification framework: (1) symptom score using the Aging Males' Symptoms (AMS) scale (score of 27 or above flagged for lab work), (2) morning testosterone draw before 10 a.m. At a local lab, (3) synchronous video visit to review labs and symptoms, and (4) prescription sent electronically to a Virginia-licensed pharmacy or compounding pharmacy of the patient's choice. Patients who do not meet the clinical threshold at step 2 are counseled on lifestyle factors associated with low testosterone, including sleep, body mass index, and alcohol intake, without a prescription being issued.

What Is the Cheapest Way to Get AndroGel in Virginia?

The least expensive path for most Virginia residents depends on insurance status. The table below summarizes the cost field:

| Scenario | Estimated Monthly Cost | |---|---| | Brand AndroGel, no insurance, no coupon | ~$510 | | Brand AndroGel, GoodRx coupon | ~$400, $450 | | Generic testosterone gel 1%, cash pay | ~$180, $260 | | Brand AndroGel, commercial insurance tier 3 | ~$50, $90 (after deductible) | | Brand AndroGel, AbbVie copay card | $0 (commercially insured, non-federal program) | | Compounded testosterone gel, 503A pharmacy | ~$120 | | Virginia Medicaid (approved PA) | $1, $4 copay |

For an uninsured Virginia resident with income below 400% of the federal poverty level, the AbbVie PAP or Virginia Medicaid enrollment (if income-eligible) produces the lowest net cost. For insured patients with high deductibles, the AbbVie copay card eliminates out-of-pocket cost entirely during the deductible accumulation period.

The STEP-1 trial (N=1,961) established that semaglutide 2.4 mg reduced body weight by 14.9% at 68 weeks versus 2.4% for placebo [24]. The relevance here is indirect but real: testosterone levels in men rise meaningfully with weight loss. A 2013 study (N=900) published in the European Journal of Endocrinology found that each 1 kg/m2 reduction in BMI corresponded to a 2% increase in total testosterone [25]. Some Virginia patients who pursue structured weight loss under GLP-1 therapy find their testosterone normalizes without pharmacological intervention, removing the AndroGel cost equation entirely.

Virginia-Specific Regulations Affecting Testosterone Gel Access

Virginia enacted no new testosterone-specific prescribing restrictions between 2023 and 2026. The state follows federal DEA scheduling for testosterone (Schedule III) and does not impose additional state-level controlled substance scheduling above the federal baseline [26].

The Virginia Board of Pharmacy conducts annual inspections of 503A compounding pharmacies operating in the state. As of the most recent inspection cycle, 14 active 503A pharmacies in Virginia hold compounding licenses for sterile and non-sterile preparations, of which testosterone gel is non-sterile [27]. Injectable testosterone cypionate preparations are sterile and subject to stricter compounding standards under USP 797 [28].

Prescribers in Virginia must register with the Prescription Monitoring Program (PMP) through the Virginia Prescription Monitoring Program (PMP AWARxE system) and check the PMP before initiating testosterone therapy in a new patient. The check documents that the patient is not receiving duplicate controlled substance prescriptions from multiple providers [29].

Virginia's collaborative pharmacy practice agreements (CPPAs) allow clinical pharmacists in collaborative practice with a physician to adjust testosterone doses and order follow-up labs within a written agreement. This model is used at several Virginia health systems, including VCU Health and Inova, to manage TRT patients efficiently between physician visits [30].

Monitoring Costs on AndroGel in Virginia

Starting AndroGel is not the only cost. Clinical guidelines recommend follow-up serum testosterone at 3 to 6 months after initiating therapy, then annually once stable, along with hematocrit monitoring to detect polycythemia. The American Urological Association's 2018 testosterone deficiency guidelines recommend checking hematocrit at baseline, at 3 to 6 months, and then annually [31].

A standard testosterone panel in Virginia (total testosterone, free testosterone, SHBG, LH, FSH) runs $60, $110 at walk-in labs such as LabCorp and Quest Diagnostics. PSA testing, recommended annually in men over 40 on testosterone therapy, adds $30, $50. Hematocrit is often included in a complete blood count at $25, $40. Annual monitoring costs therefore add $115, $200 to the total cost of therapy even before pharmacy expenses [32].

Patients on Virginia Medicaid have lab costs covered under the medical benefit without a separate PA for standard monitoring panels. Commercial insurance covers labs at the plan's laboratory benefit rate, typically a fixed copay of $10, $30 per draw [33].

Side Effects That May Alter Long-Term Cost in Virginia

Polycythemia (hematocrit above 54%) develops in an estimated 3 to 18% of men on testosterone therapy and may require dose reduction, phlebotomy, or switching to a lower-dose formulation [34]. Phlebotomy sessions in Virginia run $50, $150 at independent blood centers or are covered under medical insurance as a therapeutic procedure.

Skin transfer to female partners or children remains the primary safety concern specific to gel formulations. The FDA's 2009 black-box warning mandates patient counseling on preventing transfer [1]. Transfer risk is reduced by applying gel to the upper arms and shoulders (the approved sites for 1.62%), allowing 5 minutes drying time, and covering the application site with clothing before contact [35].

A 2010 New England Journal of Medicine trial (N=209) evaluating testosterone gel in older men with limited mobility was stopped early due to increased cardiovascular adverse events in the testosterone group (23 events vs. 5 in placebo, P<0.001) [36]. The FDA subsequently required a class label update for all testosterone products noting a potential cardiovascular risk, though the T-Trials (N=788) did not replicate the cardiovascular signal at 12 months [2]. Virginia prescribers are expected to discuss this uncertainty with patients prior to initiating therapy, per FDA label requirements.